Tina Hartert Archives
Study finds RSV may evade vaccines via rapid mutation
Mar. 9, 2023—A Vanderbilt study concluded that RSV’s ability to mutate rapidly to escape detection by the body’s immune system makes it more challenging to design and develop vaccines that can stop it from spreading.
Study explores role RSV plays in later asthma development
Jul. 21, 2022—A Vanderbilt clinical project will follow 1,950 Middle Tennessee children to determine how genes and the environment interact with RSV infection during the first year of life and contribute to asthma development
Food allergy linked to lower risk of SARS-CoV-2 infection
Jun. 3, 2022— by Nancy Humphrey People with food allergies are surprisingly less likely to become infected with SARS-CoV-2, the virus that causes COVID-19, than people without them, a study funded by the National Institutes of Health and co-led by Vanderbilt University Medical Center’s Tina Hartert, MD, MPH, has found. In addition, the Human Epidemiology and Response...
Study to determine rate of novel coronavirus infection in U.S. children
May. 12, 2020—Researchers at Vanderbilt University Medical Center (VUMC) are leading a nationwide study to determine the rate of novel coronavirus infection in U.S. children and their families.
Team explores diabetes drug’s ability to treat RSV infection
Jul. 12, 2018—A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis — inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.
RSV-HRV viral interference
May. 15, 2017—RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.
Childhood health influences focus of new NIH initiative
Sep. 29, 2016—The National Institutes of Health (NIH) recently announced it will provide $157 million in awards to launch a multi-center, seven-year initiative that will investigate how exposure to environmental factors in early development — from conception through early childhood — influences the health of children and adolescents.
Team to study RSV’s role in asthma formation
Jul. 21, 2016—Investigators in the Division of Allergy, Pulmonary and Critical Care Medicine recently received a $4.5 million Asthma and Allergic Diseases Cooperative Research Center (AADCRC) grant from the National Institutes of Allergy and Infectious Diseases (NIAID).
Medical societies honor four VUMC physicians
May. 12, 2016—Four physicians from Vanderbilt University Medical Center (VUMC) have been elected to membership in two of the nation’s oldest and most respected medical honor societies — the Association of American Physicians (AAP) and the American Society for Clinical Investigation (ASCI).
New awards honor contributions to translational research at VUMC
Nov. 5, 2015—Two physician-scientist leaders at Vanderbilt University Medical Center were honored last week with newly created awards for helping to build and nurture Vanderbilt’s vibrant culture of clinical and translational research.
Hartert to help lead Translational Science efforts
Jan. 30, 2014—Tina Hartert, M.D., MPH, professor of Medicine in the Division of Allergy, Pulmonary and Critical Care Medicine, has been named assistant vice chancellor for Translational Science.
